Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Microsurgical reconstruction effectively covers complex scalp defects but doesn't improve survival for cancer-related cases.

Eyebrow loss has many causes and requires accurate diagnosis for proper treatment.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Finasteride improves hidradenitis suppurativa in children with no adverse effects.

Aggressive scalp squamous cell carcinomas have a high death rate and need early, strong treatment.

Sorafenib after liver surgery may increase survival for some liver cancer patients.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Saw palmetto supplements may modestly improve hair regrowth with few side effects, but more research is needed.

RT1640 treatment reverses gray hair and promotes hair growth in mice.

The document concludes that careful diagnosis is crucial for chromosome 13q deletion syndrome, tamoxifen can cause reversible eye damage, finasteride may be linked to cataracts, and OCT is useful for diagnosing macular diseases.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

IMA and IMA/albumin levels don't predict alopecia areata severity.

The number of advanced breast cancer cases in women under 40 has increased, but the overall numbers are still low.

Hair transplantation with FUE is safe, effective, and better than FUT for male hair loss.

The meeting discussed medical findings, including benefits of certain treatments for cancer and heart conditions, and highlighted issues like poor adherence to preventive measures and skill gaps among interns.

Bexxar treatment led to a high response rate in patients with advanced-stage, treatment-resistant follicular lymphoma.

Hair loss, known as Androgenetic Alopecia, is often caused by hormones and can be diagnosed using noninvasive techniques. Treatments include topical minoxidil and oral finasteride, with new treatments being explored. There may also be a link between this type of hair loss and heart disease risk.

A 24-year-old woman had a rare ovarian tumor that caused male-pattern hair growth and was hard to diagnose and treat.

Children with classic congenital adrenal hyperplasia have thicker heart fat and more heart and blood vessel risk factors, especially if their condition is not well-controlled.

The document concludes that there have been significant improvements in diagnosing and treating skin diseases, including melanoma, with new techniques and therapies.

Eating more omega-3 and less omega-6 fatty acids may lower the risk of developing prostate cancer.

Blood tests for tumor cells could improve prostate cancer diagnosis and treatment; hair loss severity linked to a gene affecting prostate conditions.

Some aggressive scalp cancers are hard to treat and can be deadly, even when removed with specialized surgery.

Puberty involves complex hormonal changes, varies by gender and ethnicity, and requires careful monitoring for abnormalities.

Scientists created hair-growing skin models from stem cells, which could help treat hair loss and skin diseases.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Lipedema is a painful fat disorder in women that's hard to treat, often worsens with hormonal changes, and requires symptom-focused therapies.

The combination of TACE and Donafenib is effective and tolerable for treating unresectable liver cancer.